financetom
Business
financetom
/
Business
/
Coya Therapeutics Prices $20 Million Public Offering of Common Stock; Shares Fall Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coya Therapeutics Prices $20 Million Public Offering of Common Stock; Shares Fall Pre-Bell
Oct 24, 2025 6:27 AM

08:53 AM EDT, 10/24/2025 (MT Newswires) -- Coya Therapeutics ( COYA ) said Friday that it has priced its public offering of shares to raise up to $20 million.

The company said it is offering 3.6 million shares at $5.50 per share. Additionally, underwriters were granted an option to purchase up to 545,454 shares.

Coya said the net proceeds will be used for working capital and general corporate purposes, including funding for its clinical development plan, the company said.

The offering is expected to close on Monday, the company said.

Shares of Coya were down 10% in recent Friday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Shell Accepts Aggregate Principal Amount of $11.46 Billion in Old Notes for Exchange
Shell Accepts Aggregate Principal Amount of $11.46 Billion in Old Notes for Exchange
Oct 4, 2024
07:38 AM EDT, 10/04/2024 (MT Newswires) -- Shell (SHEL) said Friday it had accepted an aggregate princpal amount of $11.46 billion of notes validly tendered under its recent exchange offer to accept up to $12 billion maximum principal amount of old notes. The notes being tendered were from its twelve series of notes issued by Shell International Finance, in exchange...
Architectural Services Company Apogee Smashes Q2 Expectations, Hikes FY25 EPS Outlook Despite Revenue Dip
Architectural Services Company Apogee Smashes Q2 Expectations, Hikes FY25 EPS Outlook Despite Revenue Dip
Oct 4, 2024
Apogee Enterprises, Inc. ( APOG ) shares are trading higher after the company reported second-quarter sales of $342.4 million, beating the consensus estimate of $335.3 million. Revenue fell 3.2% due to lower volume. Gross margin improved by 140 basis points Y/Y to 28.4%, led by better pricing, a favorable project mix in Architectural Services, lower material costs, and reduced insurance expenses. Adjusted operating income increased 6.4% Y/Y to $43.1 million,...
UK's competition regulator clears $3.32 bln Barratt-Redrow deal
UK's competition regulator clears $3.32 bln Barratt-Redrow deal
Oct 4, 2024
Oct 4 (Reuters) - Britain's competition regulator said on Friday it has cleared Barratt's 2.52 billion pound ($3.32 billion) all-stock acquisition of smaller rival Redrow ( RDWWF ), after accepting the undertakings offered by the two homebuilders. The Competition and Markets Authority said it has decided not to refer the deal, announced in February this year, to an in-depth Phase...
Abbott Laboratories Mpox Test Approved by World Health Organization
Abbott Laboratories Mpox Test Approved by World Health Organization
Oct 4, 2024
07:37 AM EDT, 10/04/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) mpox in vitro diagnostic assay has been the first such tool approved by the World Health Organization under its emergency use procedures, the multilateral UN agency said Thursday. The WHO said Abbot's Alinity m MPXV assay will increase diagnostic capacity in countries facing mpox outbreaks. Early diagnosis of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved